Rediff.com« Back to articlePrint this article

Ranbaxy gets FDA nod for hypertension drug

April 26, 2004 17:23 IST

Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval to market Fosinopril sodium tablets in the United States.

The USFDA website on Monday said that the company had been given the go-ahead for marketing Fosinopril sodium indicated for the treatment of hypertension.

© Copyright 2025 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.